Medidata Rave CTMS
Best Enterprise CTMS for Global Pharma TrialsMedidata Rave CTMS, part of Dassault Systèmes’ Medidata Solutions, is the gold standard for global phase II–IV clinical trials. Used by 18 of the top 25 global pharmaceutical companies, Rave CTMS integrates seamlessly with Medidata Rave EDC, eTMF, and RTSM.
Key product: Multi-site visit tracking, subject enrollment, protocol deviation management, financial reconciliation, site performance dashboards
- Best for: Global pharma sponsors, large CROs, multi-site late-phase trials
- Key features: Multi-site visit tracking, subject enrollment, protocol deviation management, financial reconciliation, site performance dashboards
- AI capabilities: Predictive site performance scoring, AI-driven protocol deviation alerts, risk-based monitoring (RBM) engine
- Compliance: 21 CFR Part 11, ICH E6(R2) GCP, GDPR, EMA Annex 11, PMDA
- Differentiator: Unified Patient Cloud for DCT; broadest eClinical suite integration in market
- Weakness: High cost; 6–12 month implementation timelines; steep learning curve for new users